Fintel reports that on November 7, 2025, JP Morgan maintained coverage of BridgeBio Pharma (NasdaqGS:BBIO) with a Overweight ...

J.P. Morgan, Jefferies, Citigroup and TD Cowen are acting as joint book-running managers for the offering.

J.P. Morgan, Jefferies, Citigroup and TD Cowen are acting as joint book-running managers for the proposed offering.

Vor Biopharma Inc. (Nasdaq: VOR), a clinical-stage biotechnology company dedicated to transforming the treatment of autoimmune diseases, today announced the ...

Investing.com -- Vor Biopharma Inc (NASDAQ:VOR) stock plunged 14.9% in after-hours trading Monday after the clinical-stage biotechnology company announced plans for a $100 million public offering of ...

Investing.com -- Biohaven Ltd. (NYSE:BHVN) stock fell 7% in after-hours trading Tuesday following the company’s announcement of a $150 million public offering of common shares.

Casterra Ag Ltd. ("Casterra"), an Israeli developer of high-yield castor seed varieties and integrated castor farming ...

Weil, Gotshal & Manges energy and infrastructure partner Chris Bennett returned to Vinson & Elkins, and investment funds ...

Weil, Gotshal & Manges energy and infrastructure partner Chris Bennett returned to Vinson & Elkins, and investment funds ...

From hot tips to hard lessons – six timeless trading books that show how real success comes from consistency and discipline, ...

Ltd. announced that it has commenced an underwritten public offering of $150M of its common shares. All of the common shares to be ...

Detailed price information for Charles River Laboratories Intl (CRL-N) from The Globe and Mail including charting and trades.